Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,935,250
-$1,106,059 QoQ
Shares Held
58,300
-57.2% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 211 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. ANAB ranks #93 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ANAB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,935,250 | 58,300 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,041,309 | 90,900 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,699,024 | 76,300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,775,439 | 123,300 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,840,509 | 263,086 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,296,416 | 338,700 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,557,977 | 193,200 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,713,389 | 200,400 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,826,719 | 152,702 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,256,498 | 100,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,047,752 | 95,600 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,664,887 | 92,700 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,179,720 | 58,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,558,019 | 71,600 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $600,878 | 29,600 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,442,339 | 58,300 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,202,351 | 34,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,863,144 | 68,700 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,816,110 | 224,300 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,973,363 | 230,782 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,893,893 | 134,600 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $395,298 | 26,800 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $4,147,155 | 293,500 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||